Bavarian Nordic A/S banner

Intrinsic Value

Is BAVA undervalued or overvalued?

See the intrinsic value estimate for Bavarian Nordic A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BAVA Intrinsic Value
LOCKED
Unlock
Today vs. history

BAVA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with BAVA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BAVA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price kr236.2
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BAVA

Fundamental Analysis

What Bavarian Nordic A/S Does

Biotechnology Health Care

Bavarian Nordic is a vaccine company that develops, makes, and sells vaccines for infectious diseases. Its best-known products are vaccines for smallpox and mpox, rabies, and tick-borne encephalitis, along with a few other travel and specialty vaccines. It also works on vaccine candidates for other diseases and immune-related medicines, but its core business is finished vaccines rather than general drug development.

Headquarters
Denmark DK
Employees
1 861
IPO date
Nov 2, 1998
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bavarian Nordic A/S

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one BAVA stock?

The intrinsic value for Bavarian Nordic A/S (BAVA) under the Base Case is hidden DKK.

Is BAVA stock undervalued or overvalued?

Compared with the current market price of 236.2 DKK, the stock appears hidden.

Back to Top